High plasma C-terminal FGF-23 levels predict poor outcomes in patients with chronic kidney disease superimposed with acute kidney injury
Background: Elevated plasma C-terminal fibroblast growth factor-23 (cFGF-23) levels are associated with higher mortality in patients with chronic kidney disease (CKD) and acute kidney injury (AKI). Our study explored the outcome forecasting accuracy of cFGF-23 in critically ill patients with CKD sup...
Main Authors: | Yu-Hsing Chang, Che-Hsiung Wu, Nai-Kuan Chou, Li-Jung Tseng, i-Ping Huang, Chih-Hsien Wang, Vin-Cent Wu, Tzong-Shinn Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Therapeutic Advances in Chronic Disease |
Online Access: | https://doi.org/10.1177/2040622320964161 |
Similar Items
-
Osteocytic FGF23 and Its Kidney Function
by: Rafiou Agoro, et al.
Published: (2020-08-01) -
C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival
by: Chang Chu, et al.
Published: (2021-04-01) -
Prevalence of acute kidney injury and prognostic significance in patients with acute myocarditis.
by: Ya-Wen Yang, et al.
Published: (2012-01-01) -
Cardiac hypertrophy in chronic kidney disease—role of Aldosterone and FGF23
by: Koichi Hayashi, et al.
Published: (2018-02-01) -
New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
by: Maria L. Mace, et al.
Published: (2020-11-01)